Sales rise 35.15% to Rs 331.15 crore
Net profit of Marksans Pharma rose 119.62% to Rs 49.37 crore in the quarter ended June 2020 as against Rs 22.48 crore during the previous quarter ended June 2019. Sales rose 35.15% to Rs 331.15 crore in the quarter ended June 2020 as against Rs 245.03 crore during the previous quarter ended June 2019. ParticularsQuarter EndedJun. 2020Jun. 2019% Var.Sales331.15245.03 35 OPM %21.1413.23 -PBDT68.6532.35 112 PBT61.4027.61 122 NP49.3722.48 120Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
